These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 19025120)
1. Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors. Woodruff TM; Costantini KJ; Taylor SM; Noakes PG Adv Exp Med Biol; 2008; 632():143-58. PubMed ID: 19025120 [TBL] [Abstract][Full Text] [Related]
2. The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. Woodruff TM; Costantini KJ; Crane JW; Atkin JD; Monk PN; Taylor SM; Noakes PG J Immunol; 2008 Dec; 181(12):8727-34. PubMed ID: 19050293 [TBL] [Abstract][Full Text] [Related]
3. TDP-43 in differential diagnosis of motor neuron disorders. Dickson DW; Josephs KA; Amador-Ortiz C Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation. Han Y; Ripley B; Serada S; Naka T; Fujimoto M PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121 [TBL] [Abstract][Full Text] [Related]
5. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550 [TBL] [Abstract][Full Text] [Related]
6. The complement factor C5a receptor is upregulated in NFL-/- mouse motor neurons. Humayun S; Gohar M; Volkening K; Moisse K; Leystra-Lantz C; Mepham J; McLean J; Strong MJ J Neuroimmunol; 2009 May; 210(1-2):52-62. PubMed ID: 19286267 [TBL] [Abstract][Full Text] [Related]
7. C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice. Lobsiger CS; Boillée S; Pozniak C; Khan AM; McAlonis-Downes M; Lewcock JW; Cleveland DW Proc Natl Acad Sci U S A; 2013 Nov; 110(46):E4385-92. PubMed ID: 24170856 [TBL] [Abstract][Full Text] [Related]
8. Endosomal accumulation of APP in wobbler motor neurons reflects impaired vesicle trafficking: implications for human motor neuron disease. Palmisano R; Golfi P; Heimann P; Shaw C; Troakes C; Schmitt-John T; Bartsch JW BMC Neurosci; 2011 Mar; 12():24. PubMed ID: 21385376 [TBL] [Abstract][Full Text] [Related]
9. Ultrastructural evidence of neurofilament involvement in immune-mediated motor neuron injury. Liu YL; Guo YS; Xu L; Wu SY; Wu DX; Yang C; Li CY Neurol Res; 2008 Nov; 30(9):990-4. PubMed ID: 18662498 [TBL] [Abstract][Full Text] [Related]
10. Experimental transmissibility of mutant SOD1 motor neuron disease. Ayers JI; Fromholt S; Koch M; DeBosier A; McMahon B; Xu G; Borchelt DR Acta Neuropathol; 2014 Dec; 128(6):791-803. PubMed ID: 25262000 [TBL] [Abstract][Full Text] [Related]
11. Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS. Wootz H; Hansson I; Korhonen L; Näpänkangas U; Lindholm D Biochem Biophys Res Commun; 2004 Sep; 322(1):281-6. PubMed ID: 15313203 [TBL] [Abstract][Full Text] [Related]
13. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993 [TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Barber SC; Shaw PJ Free Radic Biol Med; 2010 Mar; 48(5):629-41. PubMed ID: 19969067 [TBL] [Abstract][Full Text] [Related]
15. Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis. Ringer C; Weihe E; Schütz B Neurobiol Dis; 2012 Jan; 45(1):547-54. PubMed ID: 21964254 [TBL] [Abstract][Full Text] [Related]
16. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Gurney ME; Pu H; Chiu AY; Dal Canto MC; Polchow CY; Alexander DD; Caliendo J; Hentati A; Kwon YW; Deng HX Science; 1994 Jun; 264(5166):1772-5. PubMed ID: 8209258 [TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507 [TBL] [Abstract][Full Text] [Related]
18. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Turner BJ; Talbot K Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652 [TBL] [Abstract][Full Text] [Related]
19. Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis. Heurich B; El Idrissi NB; Donev RM; Petri S; Claus P; Neal J; Morgan BP; Ramaglia V J Neuroimmunol; 2011 Jun; 235(1-2):104-9. PubMed ID: 21501881 [TBL] [Abstract][Full Text] [Related]
20. Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Wood-Allum CA; Barber SC; Kirby J; Heath P; Holden H; Mead R; Higginbottom A; Allen S; Beaujeux T; Alexson SE; Ince PG; Shaw PJ Brain; 2006 Jul; 129(Pt 7):1693-709. PubMed ID: 16702190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]